0001439222-23-000123.txt : 20230810
0001439222-23-000123.hdr.sgml : 20230810
20230810160715
ACCESSION NUMBER: 0001439222-23-000123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230808
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goff Brian
CENTRAL INDEX KEY: 0001546216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 231159351
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS, INC
STREET 2: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
wk-form4_1691698025.xml
FORM 4
X0508
4
2023-08-08
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0001546216
Goff Brian
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
1
1
0
0
Chief Executive Officer
1
Common stock
2023-08-08
4
M
0
22691
0
A
36770
D
Common stock
2023-08-08
4
S
0
10178
25.48
D
26592
D
Restricted stock units
2023-08-08
4
M
0
22691
0
D
Common stock
22691
45382
D
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units were granted on August 8, 2022. Beginning on August 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
/s/ William Cook, as Attorney in Fact for Brian Goff
2023-08-10